Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delphine C M Rolland

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Biomarkers in Cancer|February 27, 2016
SIGNALING PATHWAYS AS BIOMARKERSAnagh A Sahasrabuddhe, Delphine C M Rolland, Pinaki P Banerjee
Seminars in Hematology|December 22, 2018
Mass spectrometry and proteomics in hematologyDelphine C M Rolland, Megan S Lim, Kojo S J Elenitoba-Johnson
Oncotarget|January 27, 2018
A comparative global phosphoproteomics analysis of obinutuzumab (GA101) versus rituximab (RTX) against RTX sensitive and resistant Burkitt lymphoma (BL) demonstrates differential phosphorylation of signaling pathway proteins after treatmentAradhana Awasthi, Delphine C M Rolland, Janet Ayello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma ViabilityCarlos Murga-Zamalloa, Delphine C M Rolland, Avery Polk, et al.
Cancer Research|May 2, 2015
High-Frequency Targetable EGFR Mutations in Sinonasal Squamous Cell Carcinomas Arising from Inverted Sinonasal PapillomaAaron M Udager, Delphine C M Rolland, Jonathan B McHugh, et al.
Nature Communications|September 30, 2015
Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sézary syndromeMark J Kiel, Anagh A Sahasrabuddhe, Delphine C M Rolland, et al.
Nature|January 12, 2018
A metabolic function of FGFR3-TACC3 gene fusions in cancerVéronique Frattini, Stefano M Pagnotta, Tala, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2017
Functional proteogenomics reveals biomarkers and therapeutic targets in lymphomasDelphine C M Rolland, Venkatesha Basrur, Yoon-Kyung Jeon, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biomarkers in Cancer|February 27, 2016
SIGNALING PATHWAYS AS BIOMARKERSAnagh A Sahasrabuddhe, Delphine C M Rolland, Pinaki P Banerjee
Seminars in Hematology|December 22, 2018
Mass spectrometry and proteomics in hematologyDelphine C M Rolland, Megan S Lim, Kojo S J Elenitoba-Johnson
Oncotarget|January 27, 2018
A comparative global phosphoproteomics analysis of obinutuzumab (GA101) versus rituximab (RTX) against RTX sensitive and resistant Burkitt lymphoma (BL) demonstrates differential phosphorylation of signaling pathway proteins after treatmentAradhana Awasthi, Delphine C M Rolland, Janet Ayello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma ViabilityCarlos Murga-Zamalloa, Delphine C M Rolland, Avery Polk, et al.
Cancer Research|May 2, 2015
High-Frequency Targetable EGFR Mutations in Sinonasal Squamous Cell Carcinomas Arising from Inverted Sinonasal PapillomaAaron M Udager, Delphine C M Rolland, Jonathan B McHugh, et al.
Nature Communications|September 30, 2015
Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sézary syndromeMark J Kiel, Anagh A Sahasrabuddhe, Delphine C M Rolland, et al.
Nature|January 12, 2018
A metabolic function of FGFR3-TACC3 gene fusions in cancerVéronique Frattini, Stefano M Pagnotta, Tala, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2017
Functional proteogenomics reveals biomarkers and therapeutic targets in lymphomasDelphine C M Rolland, Venkatesha Basrur, Yoon-Kyung Jeon, et al.
Pageof 1